Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
11/09/2026 12:16
BRIEF-Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility Sept 11 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS:
USFDA COMPLETES INSPECTION AT UNIT'S VADODARA FACILITY
INSPECTION RESULTS IN ONE MINOR PROCEDURAL AND NO GMP-RELATED OBSERVATION
Further company coverage: SENO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees